Seven Mile Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Seven Mile Advisory's NVS Position: Q2 2026 in Review
Seven Mile Advisory reduced its Novartis (NVS) stake by 0.67% in Q2 2026, selling an estimated $4.05K and leaving 3,996 shares worth $626K. The position accounts for 0.42% of the portfolio, ranked #42.
Seven Mile Advisory first reported a position in NVS in Q2 2023 and has held it in 13 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Seven Mile Advisory held 3,996 shares of Novartis worth $626K as of Q2 2026.
- Seven Mile Advisory sold 27 Novartis shares in Q2 2026, an estimated $4.05K.
- Novartis made up 0.42% of Seven Mile Advisory's portfolio in Q2 2026, its #42 holding.
- Seven Mile Advisory first reported a position in Novartis in Q2 2023 and has held it in 13 quarters since.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.